Antibody variable domains contain "complementarity determining regions" (CDRs), which are solvent exposed loops that form the antigen binding site. Three such loops, CDR1, CDR2, and CDR3, are recognized as the canonical CDRs. However, there exists a fourth solvent-exposed loop, the DE loop, adjacent to CDR1 and CDR2 that joins the D and E strands on the antibody v-type fold. The DE loop is usually treated as a framework region, and as such, structural and genetic studies of antibodies often ignore this loop; yet, their lengths, structures, and sequences are variable and they contact the antigen in some antigen-antibody complex structures. We analyzed all of the structures and sequences of DE loops, which we refer to as H4 and L4 in the heavy and light chain variable domains respectively, as well as searched through millions of antibody sequences from both HIV-1 infected and naïve patients to look for human DE loop sequences with interesting features. Clustering the backbone conformations of the most common length of L4 (6 residues) reveals four dominant conformations, two of which contain only κ light chains, one of which contains only λ light chains, and one of which contains both κ and λ light chains. H4 loops in mammalian germlines are all of length 8 and their structures exist in only one conformational cluster. Length-8 L4 CDRs from a subset of λ5/λ6 germlines all have a backbone conformation very similar to that of the H4 length 8 cluster. Our structural classification of the DE loop uncovers its influence on CDR1 and CDR2 conformations, which in turn affect antibody binding. Furthermore, we show that H4 sequence variability exceeds that of the antibody framework in somatically mutated sequences from naïve human high-throughput sequences, and both L4 and H4 sequence variability from λ and heavy germline sequences also exceed that of germline framework regions. Finally, we identified a variety of insertions in DE loops present in dozens of structures of broadly neutralizing HIV antibodies in the PDB, as well as antibody sequences from high-throughput sequencing studies of HIVinfected individuals, thus illuminating a possible role in humoral immunity to HIV-1. Figure 2. Ramachandran plots for part of the D strand, DE loop, and part of the E strand (IMGT residues 77-90). A. Phi (x-axis) and psi (y-axis) for residues in H4, and the 3 anchor residues before and after the loop. IMGT residue number provided at the bottom of each panel. B. Phi/psi for residues in L4, and the 3 anchor residues before and after the loop.
Introduction
Antibodies utilize three hypervariable loops on each variable domain to bind antigens. These three loops are referred to as complementarity determining regions or CDRs, and were first identified by their high sequence variation relative to the rest of the variable domain sequence (1) . However, there is a fourth loop, referred to as the DE loop, which joins strands D and E in the immunoglobulin v-type fold (2,3) ( Figure 1A ). This DE loop is adjacent to CDR1 and CDR2 on the antibody heavy and light chains ( Figure   1B and 1C). In the linear sequence, the DE loop sits between CDRs 2 and 3 and is encoded by V-region gene segments (4) . The DE loop has been traditionally considered part of the antibody framework, so studies addressing the ability of specific DE loop residues to affect antibody binding (5) (6) (7) have addressed these residues as framework residues, and not part of IMGT residue Tyr87 (Chothia residue 71) to alanine, noting that this interaction mediates interaction of L1 with target antigen though a hydrogen bond between Tyr87 and Asn37 (7) . Previously we demonstrated the importance of the DE loop in redesigning an unstable anti-EGFR antibody, C10 and its affinity-matured form P2224 (8) . Because the VL region of C10 appeared to be a fusion of λ3 and λ1 gene loci, introduced most likely through PCR amplification, we redesigned the antibody framework in an attempt to stabilize the antibody and prevent antibody aggregation by grafting the sequences of the λ antibody L1, L2, and L3 CDRs onto a κ framework. We observed that the λ DE loop was different in structure and sequence from a typical κ DE loop in most antibodies. Grafting the DE loop along with L1, L2, and L3 from the P2224 λ antibody onto a κ framework produced an antibody with significantly increased thermostability, which also retained P2224's binding affinity. As a control, grafting L1, L2, and L3 while keeping the host κ DE loop sequence produced an antibody with lower stability and significantly reduced affinity.
In this paper, we analyze the structures and sequences of the DE loops of heavy and light chain variable domains in the Protein Data Bank (PDB), along with a large set of sequences from multiple high-throughput antibody sequencing studies. We first define the DE loop (which we refer to as L4 on the light chain, and H4 on the heavy chain) as IMGT residues 80-87 from Ramachandran maps of residues 77-90 of heavy and light chains in the PDB.
With these definitions, we expand on the observations presented by listing all of the common backbone/backbone and side-chain/backbone hydrogen bonds to backbone or side-chain atoms of L1, H1, and H2 that influence the conformation of these CDRs. We also correlate the structural features with antibody germline identity as defined by the IMGT database.
Finally, we show an analysis of the structures and sequences of antibodies related to broadly neutralizing antibodies (bnAbs) which neutralize HIV-1 in human patients . From the structures of HIV-1 bnAbs, we identify structures with insertions in DE loops on both the light and heavy chain which contact the antigen gp120, and compare the binding contribution of the DE loops with insertions to the rest of the CDRs in these antibodies. From sequencing studies of HIV-1 infected individuals, we identify insertions and deletions, hypersomatic mutation, and frameshift mutations in and around the DE loop region for the light and heavy chain.
The insertion and frameshift mutations are not observed in a large set of naïve antibodies, and thus may represent a mechanism in humoral immunity to HIV-1.
Results

Clustering of canonical length L4 and H4 structures
To define the regions of structural variability in both H4 and L4, we plotted the φ and ψ dihedrals of the D and E strands and the residues in between for all heavy and light chains of antibodies in the PDB (Figure 2 ).
We found that IMGT residues 77-79 and 86-90 nearly uniformly occupy the beta region of the Ramachandran map, while there is some variability in residues 80-82 and 85 of light chains and residues 81-85 of the heavy chain.
So that the starting and ending residues are opposite each other in the beta strands and that the definition of H4 and L4 represent the same regions in both domains, we define the DE loop as IMGT residues 80-87. Kabat and Chothia number the H4 region as residues 71-78 and L4 loops of length 6 as residues 66-71 (L4 loops of length 8 would require insertion codes, such as 68A, 68B). In the rest of this paper, we number the residues in the DE loops from 1 to N for DE loops of length N, such that L4 loops of length 6 are numbered 1-6, and L4 and H4 loops of length 8 are numbered 1-8. A mapping of our residue numbering to those of IMGT, Kabat, and Chothia is presented in Table 1 and 2.
We clustered the structures of L4 loops with germline lengths 6 and 8 and H4 loops of length 8 using a maximum dihedral angle metric described in Materials and Methods. In this work, we used a density-based clustering algorithm, DBSCAN (46) to identify and remove outliers and to identify common conformations within the data (see Methods). Table 3 1  80  66  82  1  80  71  82  2  81  67  83  2  81  72  83  3  82  68  84  3  82  73  84  4  85  69  87  4  83  74  85  5  86  70  88  5  84  75  86  6  87  71  89  6  85  76  87  7  86  77  88  8 87 78 89 The all-λ cluster L4-6-4 resembles L4-6-2, except it has a shift in φ 1 and ψ 2 of about 30° compared to L4-6-2. This is due to germline-encoded hydrophobic residues (Leu, Ile) at the first two residues of the DE loop in the L4-6-4 sequences (e.g. Mouse IGLV1*01, IGLV2*01; human IGLV7-43*01, IGLV7-46*01).
Across the four clusters, the changes in backbone conformation may be viewed structurally as a hinge motion away from the variable domain of the antibody, with L4-6-1 being closest to the domain, and L4-6-4 the farthest away from the domain. Figure For canonical length 8 H4 structures, clustering with DBSCAN produced a single cluster, which we refer to as H4-8-1 ( Figures 3C and 4C ). Any other clusters generated in the clustering step had fewer than 4 unique sequences.
The H4-8-1 cluster has 507 unique sequences, exhibiting far greater sequence variation than any of the L4-6 clusters. The conformation of length 8 H4 structures is structurally very similar to that of length 8 L4 structures as shown in structural alignment of the two clusters by the CDR4 stem ( Figure 5 ). 
Relationship between CDR4 conformation and conformations of CDR1 and CDR2
To describe the relationship between various L4 conformations with CDR1 and CDR2 conformations, we first calculated the occurrence of each L4-6 cluster given the various common L1 clusters (Table 4 ). Three κ L1 clusters are more than 98% L4-6-1: L1-10-1, L1-15-1, and L1-17-1. All of the remaining κ L1 clusters are 82-93% L4-6-1. For most of these the secondary cluster is L4-6-2, indicating a tendency for residue 1 in the corresponding germlines to mutate from Gly to another residue type. For the λ germlines, all of the L1 clusters except L1-14-1 are 100% L4-6-2. L1-14-1 is associated with L4-6-4, because the germlines in this cluster contain length-14 L1 loops and amino acids Leu-Ile in positions 1-2 of the DE loop.
For each L1 cluster, the distribution among the L4 clusters is provided in percent (excluding the noise cluster).
Second, we have calculated all hydrogen bonds between CDR4 and CDR1 or CDR2. Supplementary Table 1 
for some CDR clusters/lengths; and (5) hydrogen bonds between DE loop backbone atoms and CDR1 side-chain atoms that occur in L1 loops longer than 14 residues. Figure 6 shows examples from selections of hydrogen bonds between DE loop atoms and CDR1 atoms. unavailable. Instead, the backbone of L4 residue 4 is in place to make a hydrogen bond to residue 7 in L1-14 loops ( Figure 6E ). The need for this specific interaction is suggested in Table 4 , as the conformation L1-14-1 occurs exclusively with L4-6-4, because the sequences are encoded in the same germlines. As noted above, L4-6-4 requires aliphatic residues in the first two residues of L4. These are only present in human and macaque IGLV7 and IGLV8 and mouse IGLV1 and IGLV2 sequences.
Beyond backbone-backbone hydrogen bonds correlated with the arrangement of the L4 backbone atoms, we note several particular sidechain/backbone hydrogen bonds that occur uniquely with L1 conformations.
For example, residue R6 hydrogen bonds to the backbone carbonyl of L1-13-1 in 14/16 chains, whereas when the DE residue 6 is Lys, but is still paired with L1-13-1, the hydrogen bond occupancy is only 19%. As noted in previous studies (5, 48) , the OH atom of the Tyr6 side chain of the DE loop forms a hydrogen bond to the backbone nitrogen atom of residue 8 in length-11 L1 CDRs, flipping its conformation from L1-11-1 (predominantly Phe6) to L1-11-2 (predominantly Tyr6). This hydrogen bond forms in 90% of structures of L1-11-2 with a Tyr residue at position 6 of L4. When this residue is Phe6 instead, this hydrogen bond is lost, and the structure of L1 is L1-11-1, and a unique hydrogen bond instead forms between the backbone nitrogen of DE residue 3 to the carbonyl of L1-11 residue 7 ( Figure 6D ). In similar fashion, we note a new hydrogen bond of the side chain of R6 in L4-6-2 to the carbonyl backbone oxygen atoms of residues 7 and 9 of L1-12-3 structures, creating a highly stable hydrogen bond network. This is an example where the exclusive occurrence of a L1/L4 pair is associated with a unique contact between L1 and L4.
For L1-15-1 and L1-17-1, the carbonyl oxygen of DE residue 1 of L4 is not only hydrogen bonded to a backbone nitrogen atom in L1, but the backbone nitrogen atom of DE residue 1 is also hydrogen bonded to various side-chain oxygen atoms of residue 7 in L1-15-1 (Asp, Ser, or Thr; Figure   6H ), or residue 14 (Ser or Asn; Figure 6I ) in L1-17-1. Taken together, these results demonstrate that L1/L4 pairs often entail highly specific interactions, facilitated by the L4 cluster-specific arrangement of the L4 backbone, and side-chain atoms in different L4 clusters, which can provide stabilizing hydrogen bonds between L4 and L1 regardless of L4 structure.
For H4, in addition to the conserved hydrogen bond involving DE residue 4 in most H1/H4 pairs for common H1 lengths and clusters, we note several side-chain/backbone hydrogen bonds that are shared between several H1 clusters and various residues in H4. Most notably, the Arg1 residue in H4 hydrogen bonds with the backbone carbonyl of residue 10 in H1-13-1 using both the NH1 and NH2 atom in the interaction ( Figure 6F ).
For specific hydrogen bonds, the occupancy of the hydrogen bond depends highly on the H4 residue type. DE residue Asn6 uses both its side-chain oxygen atom as well as its side-chain nitrogen atom to form sidechain/backbone hydrogen bonds between residue 2, residue 5 and residue 7 of H1, stabilizing the H1-14-1 conformation with a hydrogen bond network.
As described in previous studies (6, 48) , the Arg1 side-chain forms a hydrogen bond with the backbone carbonyl of residue 3 in H2, which occurs with an occupancy of 62% in conjunction with the H2-10-2 conformation.
When this residue is instead Lys1, the occupancy of this hydrogen bond is 57% (11/21 chains with H2-10-2 and H4-8-1 with Lys at position 1).
Analysis of the sequence variability in DE loops arising from somatically mutated and germline sequences.
From a set of ~2.5 million sequences of naïve human antibodies (47) (48) (49) (50) (51) (52) , we calculated the sequence entropy in four of the most prevalent human germlines for the heavy, κ, and λ genes in the data set ( Figure 7A ), as well as the entropy of human germline sequences of the same length ( Figure 7B ). As other studies have noted (53), variability of both framework and CDR residues depends highly upon germline. We did not find any DE loops with insertions in this set, so we did not have to account for insertions in the calculation of the sequence entropy.
For H4 sequence variability, we find that in cases of somatic mutation of any one particular germline, the average sequence entropy of H4 for each of the four germlines exceeds the average sequence entropy for FR1, FR2, and FR3 of the same germline antibodies (Table 5 ). However, these DE loop residues are less variable than H1 or H2 residues within the same germlines.
For κ antibodies, the maximum sequence entropy for the most variable DE loop residues in L4 (residues 2 and 5) are heavily somatically mutated compared to the antibody framework ( Figure 7A , Table 5 ), and in some germlines (e.g. IGKV3-11*01 and IGKV1-39*01) these same residues are as variable as some L1 and L2 residues. Comparing 28 germline sequences for human κ antibodies ( Figure 7B ), we observe three highly variable residues (DE residue 2, 5, and 6), and 3
completely conserved residues (IMGT residues Gly1, Gly3 and Thr4). In the variable residues of L4, the entropy is comparable to the most variable framework residues in germlines, the average entropy does not compare to the average entropy of L1 or L2, and does not exceed the average entropy of FR1, FR2, or FR3 (Table 5 ). Within each λ germline, L4 sequences are much less somatically mutated than in κ structures ( Figure 7A ). The amount of sequence variability due to somatic mutation is less than even the most variable framework residues, and does not compare to sequence variability in L1 or L2.
However, looking at 11 germline sequences ( Figure 7B ), sequence variability is comparable to both L1 and L2 at 4 of the 6 L4 residues excluding residue GLY3, and residue ALA6. Average sequence entropy in these λ L4 sequences exceeds that of FR1, FR2, and FR3, but does not compare to L1 or L2. This indicates that sequence variability in λ L4 relates primarily to germline sequence differences, and not somatic mutation. The observations for all antibody germlines show that for H4, the average sequence entropy of the DE loop residues exceeds that of the antibody framework, and also in many cases, is comparable with the variability of H1 and H2 residues. This effect depends highly on antibody germline.
For L4, in the case of somatic mutation the average sequence entropy for the whole DE loop is less than L1 and L2, as well as FR1, FR2, and FR3.
However, sequence variation across various germline sequences is greater than L1, L2, FR1, FR2, and FR3 in λ L4 sequences, but lower in κ L4 germline sequences. 4toyH, 4tvpD*, 5cezD*, 5fyjD*, 5fykD*, 5fylD*, 5t3sD*, 5u7oD*, 5u7mD*, 5um8D*, 5utfD*, 5utyD*, 5v7jD*, 5w6dD*, 5wduD*, 5wduH*, 5wduM*, 5wduU*, 6ce0D*, 6ch7D, 6ch8D, 6ch9D, 6ck9D*, 6de7D*, 6ieqD, 6mcoD, 6mtjD, 6mdtD, 6mtnD, 6mu6D, 6mu7D, 6mu8D, 6mufD, 6mugD, 6nm6E, 6nnfD, 6nnjD The L4 and H4 structures longer than germline lengths in the PDB are almost all related to bnAbs isolated from HIV-1 patients that were part of a series of affinity matured bnAbs targeting the HIV-1 envelope gp120-gp41 trimer. In most of these structures, the elongated H4 loops make specific hydrophobic interactions, hydrogen bonds, and salt bridges with the antigen (Figure 8 ). In these structures, L4 and H4 bind the antigen epitope better than two out of the three heavy chain CDRs as well as any of the light chain CDRs, as demonstrated by the extent of antigen-buried surface area for each CDR including CDR4 (Figure 9 ). A salt bridge between R1 of H4 and an interfacial Asp of the V1-loop of gp120 also helps stabilize the antibodyantigen interface, and is observed in 7/10 unique elongated H4 sequences.
Non-canonical L4 and H4 length in HIV-1 bnAbs
Besides this interaction, much of the buried interface creates hydrophobic contacts across the antibody-antigen interface ( Figure 8B ). One inserted DE loop structure targets an antigen other than HIV-1 gp120, the engineered nanobody towards Higb2 toxin in cholera virus NB6 (PDBID 5mje, DE sequence RDSAEDSAKNTV).
Figure 8. Alignment of a subset of gp120 binding HIV-1 bnAbs representing all unique DE loop sequences. A.
Aligned structures of L4-inserted bnAbs binding to HIV-1 gp120 (one representative per unique L4 sequence). The inset shows hydrophobic contacts between the antibody-antigen interface, as well as hydrogen bonds at the antibody-antigen interface and between L1 and L4, stabilizing a unique L1 conformation. B. Aligned structures of H4 inserted bnAbs binding to HIV-1 gp120 (one representative per unique H4 sequence). The inset shows hydrophobic contacts between the antibody-antigen interface, as well as a salt bridge between the first Arg residue in H4 and the antigen
The role of the non-canonical length L4 loops is particularly interesting.
These antibodies are related to the Hu_IGLV3_21*01 germline and feature length 9 L4 loops. These loops not only directly bind antigen with hydrophobic interactions at the apex of the loop ( Figure 8A ), but also stabilize the conformation of L1 through a couple of backbone-backbone and backbone-side-chain hydrogen bonds to a serine in L1, which is sandwiched between L4 and L3. This 'L1 sandwich' motif appears to rigidify the binding conformation of the antibody light chain that buries a tremendous amount of binding surface area while binding to gp120 even in the presence of highly glycosylated elements ( Figure 8A ). The L1-14 conformations associated with these antibodies are exclusive, and no other antibody structures contain these unique conformations of L1. Evolution in L4 may stabilize L1, and enable the formation of new interactions between the antibody and antigen. 
Features of DE loop sequences from HIV-1 infected patients
In searching for HIV-1 bnAb DE loop sequences in high-throughput antibody sequences that are related to the sequences we identified in Table   6 , we scanned through ~24 million high-throughput sequences related to 13 studies of HIV-1 bnAbs. None of sequences had DE loop insertion sequences related to those in the PDB listed in Table 6 . However, in the highthroughput set, we observed 599 unique (637 total) heavy chain sequences, Figure 10A ). We verified a sampling of the frameshift causing insertions in IMGT/V-QUEST. Antibody L4 sequences with λ germlines ( Figure 10B) The majority of heavy chain insertions ( Figure 10C Figure 10C ).
Discussion
In this paper, we have analyzed sequence and structural features of encourage all research related to antibody structure to explicitly account for the DE loop structure and sequence. We make an argument for the DE loop as a fourth CDR in considering its structure compared to other CDRs, wherein it has a solvent exposed loop flanked by beta strands, its sequence entropy which in the case of the heavy chain and λ germlines sequences exceeds that of the framework residues, and in its ability to insert and mutate in response to antigen, as shown here with the motivating example of HIV-1 bnAbs. In considering the DE loop as a fourth CDR, we suggest applications for antibody design and antibody modeling. For example, when designing antibodies using the 'CDR grafting' method (56), we suggest that whenever CDR1 is grafted on the light chain, or CDR1 or CDR2 on the heavy chain, L4 or H4 should be 'co-grafted' onto the same template structure. This method will preserve contacts between L4/L1, H4/H1, or H4/H2 that are necessary for preserving the structures of CDR1 or CDR2. When considering antibody modeling, a common strategy is to use CDR and framework templates based upon sequence similarity to known structures. We suggest extra attention to the relationships of L4 sequences with their structural clusters. For example, κ antibodies with a somatic mutation at the first position of the L4 from glycine to any other residue should be modeled with representative structures from cluster L4-6-2 instead of the more common L4-6-1 conformation. A similar approach can be considered when selecting template structures for molecular replacement. Taking this information into account is more likely to recapitulate contacts observed in experimental structures. The appropriate cluster, and thus structure, for CDR1 and CDR2 often depends on the sequence and conformation of CDR4, and they should be modeled together in antibody structure prediction methods.
With high-throughput sequencing data in response to HIV-1, we have 
Materials and Methods
Antibody structure and sequence data
We compiled sequence and structure data for all antibodies from the Protein Data Bank (PDB). To collect the list of antibodies in the PDB, we used a lab maintained software, PyIgClassify (57) . PyIgClassify compiles all antibody structures from the PDB by applying a set of hidden Markov models (HMMs) for each antibody gene to all sequences in the PDB using HMMER3.0. PyIgClassify also renumbers antibodies according to a modified
Honegger-Plückthun CDR scheme and numbering system described in North et al. (48, 58) In order to identify CDRs in PyIgClassify, the software uses sequence alignment to the match states of the HMMs.
In order to identify which residues are structurally variable, we plotted φ and ψ for all residues in and around the solvent exposed DE loop (3 before the loop, and 3 after the loop, Figure 2 ). We updated PyIgClassify to recognize L4 and H4 in each antibody sequence, and subsequently assign them to residue numbers within the range of 82-89, adding insert codes appropriately for loops long to exhaust this pre-allocated range of numbers.
We determine germline by comparing each PDB sequence to a curated set of IMGT germline protein sequences with BLAST taking into account the author-provided species designation. However, these are often incorrect. We 
Analyzing antibody-antigen complex set
For non-canonical length structures, we calculated the antibodyantigen buried surface area with the Rosetta macromolecular modeling suite (59) . We calculated buried surface area as the change in antigen surface area of the CDR from the bound structure to unbound structure:
Where SA represents the surface area calculated in Rosetta using the Shrake-Rupley algorithm and a standard probe radius of 1.4 Å.
Clustering loop structures
In order to group various conformations of L4 and H4 into structural families, we implemented a density based clustering method for dihedral angles based on the DBSCAN algorithm (46) . This unsupervised learning method represents an improvement over previous implementations of internal dihedral metric clustering due to its identification of outliers in the dataset, while simultaneously finding robust clusters by identifying dense regions in the metric space which are separated by low density. DBSCAN's noise detection inherently removes outlier structures due to poor crystal structure determination or other crystallization artifacts. We used the implementation of DBSCAN in the sci-kit learn library in python.
To compare two loops i and j with identical lengths, we first calculate the dihedral similarity between two angles θ 1 and θ 2 for each pair of corresponding residues, where θ represents any chosen combination of backbone dihedrals angles ϕ, ψ, or ω:
For our purposes we chose to include ϕ, ψ, and ω, which provides the maximum capability to resolve structures with both cis-and trans-peptide bonds. Next, we take as the final clustering distance the maximum value out of the set of calculations of d for {ϕ, ψ, ω}, which we call the L ∞ norm:
We chose the L ∞ norm due to its sensitivity in separating loops which are Ramachandran φ/ψ conformation at specific residues within a cluster.
Second, clusters of varying density arise at different selections of ε and
MinPts, which may coincide with the choice of ε and MinPts that produced a merged cluster. This means that no singular selection of ε and MinPts will generate the entire set of interesting clusters. To overcome these two issues, we developed a method to select a set of final clusters after running
DBSCAN on a grid of ε and MinPts, by combining the results of each run of DBSCAN. First, we establish a parameter grid of ε and MinPts by selecting a range of both parameters, and run DBSCAN at each parameter selection. We then filter out any merged clusters by removing any clusters in which any two members of the cluster are more than 150° apart. Next, the remaining clusters that pass the merge filtering criterion are treated as nodes on a graph, where the nodes have edges connected to them based on the calculation of Simpson's similarity score:
Finally, for each connected subgraph with n nodes, we take the final cluster of that subgraph as the union of all nodes n within the connected subgraph. This produces a final clustering set with clusters of varying density, without including merged clusters.
Following the determination of the final cluster set, we determined cluster representatives using angular statistical analysis. For a given cluster C consisting of N data points, for each structure i we calculate the average distance d i to all other points j in the same cluster C:
We choose the cluster representative as the structure which has the lowest d i of all of the structures.
Identifying important hydrogen bonds between CDR4 and CDR1/CDR2
We calculated all hydrogen bonds between CDR4, CDR1, and CDR2
using Rosetta's distance and orientation-dependent hydrogen bond energy accessed through the report_hbonds_for_plugin.<release> available in the public release of Rosetta3. We used the resulting contact information to find
∑ important contacts that are either frequent or unique over several CDRlengths and germlines. We analyzed the hydrogen bonds between all CDR1-CDR4 and CDR2-CDR4 pairs for which both CDR1 and CDR4 have defined cluster membership. We then calculated the hydrogen bond occupancy for a particular hydrogen bond as the following:
High-throughput sequence analysis of naïve human antibodies
We accessed high-throughput sequencing data through the 
We calculated H only for residues up until the conserved cysteine before CDR3 on both the light and heavy chains. PDF results of all of our IMGT/V-QUEST queries are supplied in the supplemental data. 
High-throughput sequence analysis of HIV-1 bnABs
H = − p i log 2 p i i=1,
